Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
12/2000
12/07/2000WO2000073274A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
12/07/2000WO2000073264A1 Cell proliferation inhibitors
12/07/2000CA2375188A1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
12/07/2000CA2375186A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000CA2371092A1 Cell proliferation inhibitors
12/06/2000EP1057818A1 PHENYLPIPERAZINE DERIVATIVES AS INTEGRIN ALPHAvBETA3 ANTAGONISTS
12/06/2000EP1056732A2 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
12/05/2000US6156937 Nonionic surfactants; water and oil repellency
12/05/2000US6156893 Process for the preparation of (1S,4R)- or (1R,4S)- 4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol
11/2000
11/30/2000WO2000071540A1 Hydrochloride of fused-heterocycle compound
11/30/2000WO2000071522A1 Benzimidazole derivatives and their use as methionyl t-rna synthetase inhibitors
11/30/2000DE19924819A1 Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren) Substituted Phenylcyclohexancarbonsäurebenzylamid (adenosine uptake inhibitors)
11/30/2000DE19924818A1 Substituierte Phenylcyclohexancarbonsäureamide Substituted Phenylcyclohexancarbonsäureamide
11/30/2000DE19924050A1 Verfahren zur Herstellung von Alken-Verbindungen Process for the preparation of alkene compounds
11/29/2000EP1055653A2 Process for the preparation of alkenyl compounds
11/29/2000EP1054870A1 Heterocyclic topoisomerase poisons
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000CN1058966C Producing process for crystal of z-oxyethyl -1-[2'-(1H-tetrazole-5-radical) diphenyl-4-(methyl) benzimidazole-7-hydroxy acid 1-(cyclohexyloxy)
11/28/2000US6153763 A microbicides comprising an imidazole ring
11/28/2000US6153759 Herbicide comprising a 5-membered or 6-membered heterocyclic, saturated or unsaturated radical containing one to three hetero atoms selected from the group consisting of oxygen, sulfur and nitrogen
11/23/2000WO2000069857A1 Process for making fused-ring imidazo-containing compounds
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069831A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000043371A3 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000DE19922462A1 New phenylureidobenzyl-substituted spiro-imidazolidinedione derivatives, are inhibitors of leukocyte adhesion or migration or VLA-4 receptors, useful e.g. for treating inflammatory or allergic disease
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/23/2000CA2372469A1 Process for making fused-ring imidazo-containing compounds
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/21/2000US6150530 Amidation of amine with acid
11/21/2000US6150394 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
11/21/2000US6150380 Crystalline form of omeprazole
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/16/2000WO2000068213A1 Substituted bicyclic compounds
11/16/2000WO2000068206A1 Heterocyclically substituted benzimidazoles, the production and application thereof
11/16/2000WO2000068204A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000041669A3 Benzimidazole vascular damaging agents
11/16/2000WO2000041469A3 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS
11/16/2000WO2000015634A3 Hiv protease inhibitors
11/16/2000CA2373076A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
11/15/2000EP1052250A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066564A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000WO2000066120A1 Novel catechols as antimicrobial agents
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000DE19921424A1 Substituierte Benzoylketone Substituted benzoyl ketones
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372279A1 Compositions containing benzimidazolones and progestogens
11/09/2000CA2372079A1 Novel catechols as antimicrobial agents
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/09/2000CA2366805A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
11/07/2000US6143771 Benzimidazole derivative drugs
11/07/2000US6143747 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000EP1047672A1 Process for preparing sparingly soluble aromatic amines
11/01/2000CN1058004C Heterocyclo-benzoylguanidin
10/2000
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6139863 Suppositories
10/26/2000WO2000063180A1 Bis-benzazoles and their use as antineoplastic agents
10/26/2000WO2000063158A1 Method for nitrating aniline derivatives
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/25/2000EP1045843A1 Inhibitors of farnesyl-protein transferase
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271343A Utilizing spirocyclic phenyl keto-enols as pesticides and herbicides
10/24/2000US6137007 Enantiomer compositions of (1R,4S)-1-butyrylamino-4-(hydroxymethyl)-2-cyclopentene
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000DE19917524A1 Regioselective preparation of alkyl 4-alkanoylamino-3-alkyl-5-nitrobenzoic acid derivatives, useful as intermediates for benzimidazole derivative drugs, by nitration of 5-unsubstituted analogs under controlled conditions
10/19/2000DE19916460A1 New heterocyclyl-benzimidazole carboxamide derivatives, useful for treating e.g. neurodegenerative diseases, epilepsy, ischemic damage, myocardial infarction, tumors, inflammation and diabetes
10/19/2000CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044199A1 Heterocyclic topoisomerase poisons
10/18/2000EP1044187A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia
10/18/2000EP1043977A1 Oral pharmaceutical pulsed release dosage form
10/18/2000EP1043976A1 Oral pharmaceutical extended release dosage form
10/17/2000US6133309 Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists
10/12/2000WO2000059905A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059889A1 α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES
10/12/2000WO2000059888A1 N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators
10/12/2000WO2000059887A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics
10/12/2000WO2000059886A2 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors
10/12/2000WO2000059883A2 Method for producing n-aryl-aza-heterocycles in the presence of cesium carbonate
10/12/2000WO2000059878A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF
10/12/2000WO1999064039A9 Bradykinin antagonists
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000CA2369871A1 .alpha.-substituted carboxylic acid derivatives
10/12/2000CA2369557A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of gabaa receptors
10/12/2000CA2369553A1 N-benzimidazolylmethyl and n-indolylmethyl-benzamides and their use as crf modulators
10/12/2000CA2369549A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics
10/12/2000CA2369544A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives:selective modulators of bradykinin b2 receptors
10/12/2000CA2369005A1 Inhibitors of lfa-1 binding to icams and uses thereof
1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 154